Home › Chronic Progressive Multiple Sclerosis › Colorado
Chronic Progressive Multiple Sclerosis clinical trials in Colorado
3 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in Colorado.
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Advanced Neurology of Colorado, LLC, Fort Collins
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Oct 30, 2026 · NCT07609719Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Rocky Mountain Multiple Sclerosis Center, University of Colorado School of Medicine, Aurora
RecruitingPhase 3
Ages 18 to 55 · All sexes · Updated Oct 20, 2026 · NCT04047628A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- UC Health Neuroscience Ctr, Aurora
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Oct 13, 2026 · NCT07225504From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.